Hypertension and cognitive dysfunction: a narrative review

키워드

참고문헌 (75)

1. Lackland DT, "Global burden of cardiovascular disease and stroke : hypertension at the core", Can J Cardiol, 31, pp.569~571 (2015)
2. Manolio TA, "Hypertension and cognitive function : pathophysiologic effects of hypertension on the brain", Curr Hypertens Rep, 5, pp.255~261 (2003)
3. Fratiglioni L, "Worldwide prevalence and incidence of dementia", Drugs Aging, 15, pp.365~375 (1999)
4. Kearney PM, "Global burden of hypertension : analysis of worldwide data", Lancet, 365, pp.217~223 (2005)
5. Farmer ME, "Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance : the Framingham Study", J Clin Epidemiol, 43, pp.475~480 (1990)
6. Gottesman RF, "Midlife hypertension and 20-year cognitive change : the atherosclerosis risk in communities neurocognitive study", JAMA Neurol, 71, pp.1218~1227 (2014)
7. Swan GE, "Association of midlife blood pressure to late-life cognitive decline and brain morphology", Neurology, 51, pp.986~993 (1998)
8. Launer LJ, "The association between midlife blood pressure levels and late-life cognitive function : the Honolulu-Asia Aging Study", JAMA, 274, pp.1846~1851 (1995)
9. Gottesman RF, "Associations between midlife vascular risk factors and 25-year incident dementia in the Atherosclerosis Risk in Communities(ARIC)Cohort", JAMA Neurol, 74, pp.1246~1254 (2017)
10. Whitmer RA, "Midlife cardiovascular risk factors and risk of dementia in late life", Neurology, 64, pp.277~281 (2005)
11. Kivipelto M, "Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease", Arch Neurol, 62, pp.1556~1560 (2005)
12. Kivipelto M, "Midlife vascular risk factors and late-life mild cognitive impairment : a population-based study", Neurology, 56, pp.1683~1689 (2001)
13. Launer LJ, "Midlife blood pressure and dementia : the Honolulu-Asia aging study", Neurobiol Aging, 21, pp.49~55 (2000)
14. Ou YN, "Blood pressure and risks of cognitive impairment and dementia : a systematic review and meta-analysis of 209 prospective studies", Hypertension, 76, pp.217~225 (2020)
15. Freitag MH, "Midlife pulse pressure and incidence of dementia : the Honolulu-Asia Aging Study", Stroke, 37, pp.33~37 (2006)
16. Nation DA, "Pulse pressure is associated with early brain atrophy and cognitive decline : modifying effects of APOE-ε4", Alzheimer Dis Assoc Disord, 30, pp.210~215 (2016)
17. Kivipelto M, "Midlife vascular risk factors and Alzheimer’s disease in later life : longitudinal, population based study", BMJ, 322, pp.1447~1451 (2001)
18. Kennelly SP, "Blood pressure and the risk for dementia : a double edged sword", Ageing Res Rev, 8, pp.61~70 (2009)
19. Waldstein SR, "Hypertension and neuropsychological performance in men : interactive effects of age", Health Psychol, 15, pp.102~109 (1996)
20. Goldstein FC, "The relationship between cognitive functioning and the JNC-8 guidelines for hypertension in older adults", J Gerontol A Biol Sci Med Sci, 72, pp.121~126 (2017)
21. Erkinjuntti T, "Subcortical vascular dementia", Cerebrovasc Dis, 13(Suppl 2), pp.58~60 (2002)
22. Desmond DW, "Cognition and white matter lesions", Cerebrovasc Dis, 13(Suppl 2), pp.53~57 (2002)
23. Iadecola C, "Neurovascular and cognitive dysfunction in hypertension", Circ Res, 124, pp.1025~1044 (2019)
24. Smith EE, "Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms", PLoS One, 13, pp.e0191345~ (2018)
25. Alexander GE, "Functional architecture of basal ganglia circuits : neural substrates of parallel processing", Trends Neurosci, 13, pp.266~271 (1990)
26. Reed BR, "Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease", Brain, 130(Pt 3), pp.731~739 (2007)
27. Hestad K, "Blood pressure in different dementia disorders, mild cognitive impairment, and subjective cognitive decline", Front Aging Neurosci, 12, pp.257~ (2020)
28. Barba R, "Poststroke dementia : clinical features and risk factors", Stroke, 31, pp.1494~1501 (2000)
29. Phelps EB, "Essential reviews in geriatric psychiatry", pp.349~353 (2022), Springer Cham
30. Power MC, "The association between blood pressure and incident Alzheimer disease : a systematic review and meta-analysis", Epidemiology, 22, pp.646~659 (2011)
31. Goldstein FC, "High blood pressure and cognitive decline in mild cognitive impairment", J Am Geriatr Soc, 61, pp.67~73 (2013)
32. Reitz C, "Hypertension and the risk of mild cognitive impairment", Arch Neurol, 64, pp.1734~1740 (2007)
33. Golimstok A, "Cardiovascular risk factors and frontotemporal dementia : a case-control study", Transl Neurodegener, 3, pp.13~ (2014)
34. Atkins ER, "Cerebrovascular risk factors in early-onset dementia", J Neurol Neurosurg Psychiatry, 83, pp.666~667 (2012)
35. Cheng CK, "Metabolic risk factors of Alzheimer’s disease, dementia with Lewy bodies, and normal elderly : a population-based study", Behav Neurol, 2018, pp.8312346~ (2018)
36. Hu X, "Cerebral vascular disease and neurovascular injury in ischemic stroke", Circ Res, 120, pp.449~471 (2017)
37. Watase H, "Carotid artery remodeling is segment specific : an in vivo study by cardiovascular magnetic resonance imaging", Circulation, 132(Suppl 3), pp.A18848~ (2015)
38. Iulita MF, "Arterial stiffness, cognitive impairment and dementia : confounding factor or real risk?", J Neurochem, 144, pp.527~548 (2018)
39. Ogola BO, "New insights into arterial stiffening : does sex matter?", Am J Physiol Heart Circ Physiol, 315, pp.H1073~87 (2018)
40. Benarroch EE, "Neuroscience for clinicians: basic processes, circuits, disease mechanisms, and therapeutic implications" (2021), Oxford University Press
41. Iadecola C, "The neurovascular unit coming of age : a journey through neurovascular coupling in health and disease", Neuron, 96, pp.17~42 (2017)
42. Back SA, "Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation", Nat Med, 11, pp.966~972 (2005)
43. Joutel A, "Pathogenesis of white matter changes in cerebral small vessel diseases : beyond vessel-intrinsic mechanisms", Clin Sci(Lond), 131, pp.635~651 (2017)
44. Simpson JE, "White matter lesions in an unselected cohort of the elderly : astrocytic, microglial and oligodendrocyte precursor cell responses", Neuropathol Appl Neurobiol, 33, pp.410~419 (2007)
45. Muñoz Maniega S, "Integrity of normal-appearing white matter : influence of age, visible lesion burden and hypertension in patients with small-vessel disease", J Cereb Blood Flow Metab, 37, pp.644~656 (2017)
46. Kusano Y, "Role of adenosine A2 receptors in regulation of cerebral blood flow during induced hypotension", J Cereb Blood Flow Metab, 30, pp.808~815 (2010)
47. Appelman AP, "White matter lesions and brain atrophy : more than shared risk factors? : a systematic review", Cerebrovasc Dis, 28, pp.227~242 (2009)
48. Gottesman RF, "Association between midlife vascular risk factors and estimated brain amyloid deposition", JAMA, 317, pp.1443~1450 (2017)
49. Vemuri P, "Age, vascular health, and Alzheimer disease biomarkers in an elderly sample", Ann Neurol, 82, pp.706~718 (2017)
50. Arvanitakis Z, "Author response : late-life blood pressure association with cerebrovascular and Alzheimer disease pathology", Neurology, 92, pp.732~ (2019)
51. Kester MI, "Joint effect of hypertension and APOE genotype on CSF biomarkers for Alzheimer’s disease", J Alzheimers Dis, 20, pp.1083~1090 (2010)
52. Faraco G, "Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP", J Cereb Blood Flow Metab, 36, pp.241~252 (2016)
53. Azarpazhooh MR, "Concomitant vascular and neurodegenerative pathologies double the risk of dementia", Alzheimers Dement, 14, pp.148~156 (2018)
54. Austin SA, "Loss of endothelial nitric oxide synthase promotes p25 generation and tau phosphorylation in a murine model of Alzheimer’s disease", Circ Res, 119, pp.1128~1134 (2016)
55. Tian M, "Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains", FEBS Lett, 586, pp.3737~3745 (2012)
56. Korf ES, "Midlife blood pressure and the risk of hippocampal atrophy : the Honolulu Asia Aging Study", Hypertension, 44, pp.29~34 (2004)
57. Applegate WB, "Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program", Arch Intern Med, 154, pp.2154~2160 (1994)
58. Forette F, "Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe(Syst-Eur)trial", Lancet, 352, pp.1347~1351 (1998)
59. Forette F, "The prevention of dementia with antihypertensive treatment : new evidence from the Systolic Hypertension in Europe(Syst-Eur)study", Arch Intern Med, 162, pp.2046~2052 (2002)
60. Tzourio C, "Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease", Arch Intern Med, 163, pp.1069~1075 (2003)
61. Peters R, "Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment(HYVET-COG) : a double-blind, placebo controlled trial", Lancet Neurol, 7, pp.683~689 (2008)
62. Bosch J, "Heart outcomes prevention evaluation : use of ramipril in preventing stroke : double blind randomised trial", BMJ, 324, pp.699~702 (2002)
63. Aronow WS, "Hypertension and cognitive impairment", Ann Transl Med, 5, pp.259~ (2017)
64. Gupta A, "Treatment of hypertension reduces cognitive decline in older adults : a systematic review and meta-analysis", BMJ Open, 10, pp.e038971~ (2020)
65. Hughes D, "Association of blood pressure lowering with incident dementia or cognitive impairment : a systematic review and meta-analysis", JAMA, 323, pp.1934~1944 (2020)
66. Mossello E, "Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs", JAMA Intern Med, 175, pp.578~585 (2015)
67. Yang W, "Effects of antihypertensive drugs on cognitive function in elderly patients with hypertension : a review", Aging Dis, 12, pp.841~851 (2021)
68. Dufouil C, "Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke : the PROGRESS(Perindopril Protection Against Recurrent Stroke Study)magnetic resonance imaging substudy", Circulation, 112, pp.1644~1650 (2005)
69. Chuang YF, "Use of diuretics is associated with reduced risk of Alzheimer’s disease : the Cache County Study", Neurobiol Aging, 35, pp.2429~2435 (2014)
70. Peters R, "Investigation of antihypertensive class, dementia, and cognitive decline : a meta-analysis", Neurology, 94, pp.e267~81 (2020)
71. Hanon O, "Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function : primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study", J Hypertens, 26, pp.1642~1650 (2008)
72. Radaideh GA, "Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function : analysis of Middle East data from the OSCAR study", Vasc Health Risk Manag, 7, pp.491~495 (2011)
73. Kalra L, "Antihypertensive drugs decrease risk of Alzheimer disease : Ginkgo Evaluation of Memory Study", Neurology, 82, pp.1192~ (2014)
74. Gelber RP, "Antihypertensive medication use and risk of cognitive impairment : the Honolulu-Asia Aging Study", Neurology, 81, pp.888~895 (2013)
75. Xu W, "Meta-analysis of modifiable risk factors for Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 86, pp.1299~1306 (2015)

관련 논문AI추천